Explanatory note

These Regulations, which come into force on 12th March 2012, revoke the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2012. The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2012, which were made on 4th February 2012 and if not revoked by these Regulations would have come into force on 28th March 2012, would have amended the Misuse of Drugs Regulations 2001 (the “2001 Regulations”) by adding: desoxypipradrol and other pipradrol‑related compounds to Schedule 1 to the 2001 Regulations; 7‑bromo‑5‑(2‑chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (commonly known as phenazepam), and any ester or ether of pipradrol, or any stereoisomeric form or salt or preparation or other product of such an ester or ether, to Schedule 3 to the 2001 Regulations; and 7-Hydroxy-dehydroepiandrosterone and 7‑Keto‑dehydroepiandrosterone to Schedule 4 to the 2001 Regulations. The schedule in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug.